These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 8527541
1. Meropenem versus tobramycin plus clindamycin for treatment of intraabdominal infections: results of a prospective, randomized, double-blind clinical trial. Condon RE, Walker AP, Sirinek KR, White PW, Fabian TC, Nichols RL, Wilson SE. Clin Infect Dis; 1995 Sep; 21(3):544-50. PubMed ID: 8527541 [Abstract] [Full Text] [Related]
2. Results of a randomized, multicenter trial of meropenem versus clindamycin/tobramycin for the treatment of intra-abdominal infections. Wilson SE. Clin Infect Dis; 1997 Feb; 24 Suppl 2():S197-206. PubMed ID: 9126694 [Abstract] [Full Text] [Related]
8. Prospective, randomized, double-blind comparison of metronidazole and tobramycin with clindamycin and tobramycin in the treatment of intra-abdominal sepsis. Smith JA, Skidmore AG, Forward AD, Clarke AM, Sutherland E. Ann Surg; 1980 Aug; 192(2):213-20. PubMed ID: 6996625 [Abstract] [Full Text] [Related]
9. Comparison of the activity of meropenem with that of other agents in the treatment of intraabdominal, obstetric/gynecologic, and skin and soft tissue. Pitkin D, Sheikh W, Wilson S, Hemsell D, Nichols R, Nadler H, Dowzicky M. Clin Infect Dis; 1995 Jun; 20 Suppl 2():S372-5. PubMed ID: 7548602 [Abstract] [Full Text] [Related]
10. Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program. Mazuski JE, Gasink LB, Armstrong J, Broadhurst H, Stone GG, Rank D, Llorens L, Newell P, Pachl J. Clin Infect Dis; 2016 Jun 01; 62(11):1380-1389. PubMed ID: 26962078 [Abstract] [Full Text] [Related]
11. A comparative analysis of aztreonam + clindamycin versus tobramycin + clindamycin or amikacin + mezlocillin in the treatment of gram-negative lower respiratory tract infections. Rivera-Vazquez CR, Ramirez-Ronda CH, Rodriguez JR, Saavedra S. Chemotherapy; 1989 Jun 01; 35 Suppl 1():89-100. PubMed ID: 2659296 [Abstract] [Full Text] [Related]
12. Cefoxitin plus tobramycin and clindamycin plus tobramycin. A prospective randomized comparison in the therapy of mixed aerobic/anaerobic infections. Nicolle LE, Harding GK, Louie TJ, Thomson MJ, Blanchard RJ. Arch Surg; 1986 Aug 01; 121(8):891-6. PubMed ID: 3524511 [Abstract] [Full Text] [Related]
14. Comparison of aztreonam plus clindamycin with tobramycin plus clindamycin in the treatment of intra-abdominal infections. Birolini D, Moraes MF, de Souza OS. Chemotherapy; 1989 Aug 01; 35 Suppl 1():49-57. PubMed ID: 2659290 [Abstract] [Full Text] [Related]
19. High-dose tobramycin combined with clindamycin or lincomycin in the treatment of septic peritonitis and intraabdominal sepsis. Muth L, Edén T. Acta Chir Scand; 1981 Sep 01; 147(5):339-46. PubMed ID: 7324760 [Abstract] [Full Text] [Related]